Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial DNA depletion syndrome in which the cause of the disease is a mutation in the OPA1 gene.
Features include always present findings: Severe backward arching of the body (opisthotonus), Hypertonia, Increased circulating lactate concentration, and Profound global developmental delay and others; and common findings: Skeletal muscle atrophy, Axial hypotonia, Increased CSF lactate, and Caesarean section and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 4 | Skeletal muscle atrophy, Axial hypotonia, Depletion of mitochondrial DNA in muscle tissue |
Lab test results | 3 | Increased circulating lactate concentration, Decreased activity of mitochondrial complex I, Decreased activity of mitochondrial complex IV |
Bones and joints | 2 | Skeletal muscle atrophy, Severe backward arching of the body (opisthotonus) |
Eyes | 2 | Retinal degeneration, Damage to the optic nerve (optic atrophy) |
Brain and nerves | 1 | Profound global developmental delay |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Heart and blood vessels | 1 | Thickened heart muscle (hypertrophic cardiomyopathy) |
Digestive system | 1 | Feeding difficulties in infancy |
Lungs and breathing | 1 | Apnea |
OPA1 encodes OPA1 mitochondrial dynamin like GTPase (960 aa). Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function. Highest expression in Cells EBV-transformed lymphocytes (41.7 TPM) and Cells Cultured fibroblasts (33.7 TPM).
Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type) is associated with mutations in the OPA1 gene on chromosome 3.
The OPA1 protein participates in Cellular response to mitochondrial stress pathway.
OPA1 is classified as a druggable target (Enzyme and Transporter categories) with score 0.0.
Genetic testing for OPA1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type) has been reported in the published literature.
Phenotype severity distribution: 11 always present features, 9 common features.
No clinical trials have been registered for mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type).
33 publications have been identified in PubMed for mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type). Research spans Basic Science / Preclinical (39%), Review / Meta-Analysis (27%), and Case Report / Case Series (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 13 | 39% |
Research summaries | 9 | 27% |
Patient case studies | 4 | 12% |
Testing and diagnosis research | 3 | 9% |
New treatment approaches | 2 | 6% |
Clinical study results | 1 | 3% |
Disease patterns and progression | 1 | 3% |
Nieto-Bona MP (2026). [PMID: 41751363](https://pubmed.ncbi.nlm.nih.gov/41751363/). *Biomedicines*. [Review / Meta-Analysis]
Menacho C (2026). [PMID: 42009687](https://pubmed.ncbi.nlm.nih.gov/42009687/). *Nat Commun*. [Diagnostic / Biomarker]
Varga L (2026). [PMID: 41664274](https://pubmed.ncbi.nlm.nih.gov/41664274/). *Ear Hear*. [Diagnostic / Biomarker]
Kleefeld F (2026). [PMID: 41639907](https://pubmed.ncbi.nlm.nih.gov/41639907/). *Acta Neuropathol Commun*. [Basic Science / Preclinical]
Xu J (2026). [PMID: 41559004](https://pubmed.ncbi.nlm.nih.gov/41559004/). *Mol Genet Genomic Med*. [Review / Meta-Analysis]
Damiano M (2026). [PMID: 41729327](https://pubmed.ncbi.nlm.nih.gov/41729327/). *J Neurol*. [Basic Science / Preclinical]
Vettiatil D (2026). [PMID: 41662332](https://pubmed.ncbi.nlm.nih.gov/41662332/). *Dev Neurosci*. [Basic Science / Preclinical]
Kawakita M (2026). [PMID: 41898875](https://pubmed.ncbi.nlm.nih.gov/41898875/). *Genes (Basel)*. [Epidemiology / Natural History]
Luo J (2026). [PMID: 40767000](https://pubmed.ncbi.nlm.nih.gov/40767000/). *Cell Prolif*. [Basic Science / Preclinical]
Wang H (2026). [PMID: 42230411](https://pubmed.ncbi.nlm.nih.gov/42230411/). *Funct Integr Genomics*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 21, 2026, 4:51 AM UTC
Online Mendelian Inheritance in Man